WO2003003986A3 - Parathyroid hormone antibodies and related methods - Google Patents
Parathyroid hormone antibodies and related methods Download PDFInfo
- Publication number
- WO2003003986A3 WO2003003986A3 PCT/US2002/021356 US0221356W WO03003986A3 WO 2003003986 A3 WO2003003986 A3 WO 2003003986A3 US 0221356 W US0221356 W US 0221356W WO 03003986 A3 WO03003986 A3 WO 03003986A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- parathyroid hormone
- related methods
- antibodies
- hormone antibodies
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02752184A EP1455821B1 (en) | 2001-07-03 | 2002-07-03 | Parathyroid hormone antibodies and related methods |
AT02752184T ATE490785T1 (en) | 2001-07-03 | 2002-07-03 | PARATHORMONE ANTIBODIES AND RELATED METHODS |
DE60238555T DE60238555D1 (en) | 2001-07-03 | 2002-07-03 | PARATHORMONE ANTIBODIES AND ASSOCIATED METHODS |
JP2003510000A JP2004536831A (en) | 2001-07-03 | 2002-07-03 | Parathyroid hormone antibodies and related methods |
AU2002354806A AU2002354806A1 (en) | 2001-07-03 | 2002-07-03 | Parathyroid hormone antibodies and related methods |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/898,398 | 2001-07-03 | ||
US09/898,398 US20030082179A1 (en) | 2001-07-03 | 2001-07-03 | Parathyroid hormone antibodies and related methods |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003003986A2 WO2003003986A2 (en) | 2003-01-16 |
WO2003003986A3 true WO2003003986A3 (en) | 2004-07-01 |
Family
ID=25409386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/021356 WO2003003986A2 (en) | 2001-07-03 | 2002-07-03 | Parathyroid hormone antibodies and related methods |
Country Status (7)
Country | Link |
---|---|
US (4) | US20030082179A1 (en) |
EP (1) | EP1455821B1 (en) |
JP (1) | JP2004536831A (en) |
AT (1) | ATE490785T1 (en) |
AU (1) | AU2002354806A1 (en) |
DE (1) | DE60238555D1 (en) |
WO (1) | WO2003003986A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7820393B2 (en) * | 1999-01-14 | 2010-10-26 | Scantibodies Laboratory, Inc. | Methods, kits and antibodies for detecting parathyroid hormone |
US6689566B1 (en) * | 1999-01-14 | 2004-02-10 | Scantibodies Laboratory, Inc. | Methods, kits, and antibodies for detecting parathyroid hormone |
US7226749B2 (en) * | 2000-12-05 | 2007-06-05 | Zahradnik Richard J | Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
US7318925B2 (en) * | 2003-08-08 | 2008-01-15 | Amgen Fremont, Inc. | Methods of use for antibodies against parathyroid hormone |
ES2321088T3 (en) * | 2003-08-08 | 2009-06-02 | Amgen Fremont Inc. | ANTIBODIES DIRECTED AGAINST THE PARTIROID HORMONE (PTH) AND USES OF THE SAME. |
GB0329146D0 (en) * | 2003-12-16 | 2004-01-21 | Glaxosmithkline Biolog Sa | Vaccine |
US7959920B2 (en) * | 2005-09-06 | 2011-06-14 | Scantibodies Laboratory, Inc. | Methods of making and using antibodies directed to parathyroid hormone |
EP2133695A1 (en) * | 2008-06-12 | 2009-12-16 | Koninklijke Philips Electronics N.V. | Parathyroid hormone assay |
BR112012005331A2 (en) † | 2009-09-14 | 2019-09-24 | Koninl Philips Electronics Nv | "Immunoassay for detecting an analyte in a sample, method for detecting analytes in a sample, biosensor device, and appropriate part kit for detecting an analyte in a sample" |
KR101882533B1 (en) * | 2010-08-31 | 2018-07-26 | 교와 메덱스 가부시키가이샤 | Method for measuring fibroblast growth factor-23 and reagent therefor |
EP2631247A1 (en) | 2012-02-22 | 2013-08-28 | Immundiagnostik AG | Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress |
EP2775306B1 (en) | 2013-03-08 | 2018-06-27 | Immundiagnostik AG | Non-oxidized, biological active parathyroid hormone determines mortality in hemodialysis patients |
KR101949405B1 (en) * | 2016-10-21 | 2019-02-18 | 이화여자대학교 산학협력단 | Animal model having hypoparathyroidism and method for producing the same |
CN107255726B (en) * | 2017-08-02 | 2018-09-14 | 江苏省原子医学研究所 | Quantitatively detect the fluorescence immune chromatography test paper and preparation method thereof of human parathyroid hormone |
WO2019141791A1 (en) | 2018-01-17 | 2019-07-25 | Immundiagnostik Ag | Biomarker predicting coronary artery disease |
KR20210120009A (en) * | 2019-01-11 | 2021-10-06 | 라디우스 헬쓰, 인코포레이티드 | Methods for Detection of Neutralizing Antibodies to Parathyroid Hormone (PTH) and Parathyroid Hormone-Related Peptide (PTHRP) Analogs |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US33188A (en) * | 1861-09-03 | Improvement in mounting glaziers diamonds | ||
US3880934A (en) | 1972-02-10 | 1975-04-29 | Syntex Inc | Nitrophenyloxy-butanediols |
US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
US4066410A (en) * | 1975-09-15 | 1978-01-03 | Nuclear-Medical Laboratories, Inc. | Thyroid hormone assay |
US4380580A (en) * | 1978-04-10 | 1983-04-19 | Miles Laboratories, Inc. | Heterogenous chemiluminescent specific binding assay |
US4369138A (en) * | 1980-07-15 | 1983-01-18 | Immuno Nuclear Corporation | Parathyroid radioimmunoassay |
SE453510B (en) * | 1980-12-29 | 1988-02-08 | Toyo Jozo Kk | PEPTIME FOR ANALYSIS OF HUMANT PARATYROID HORMON |
US4508828A (en) * | 1983-03-21 | 1985-04-02 | Immuno Nuclear Corporation | Bioassay of parathyroid hormone |
JP2598801B2 (en) * | 1986-07-18 | 1997-04-09 | ザ ユニバーシティー オブ メルボルン | Malignant-PTHrP active protein in humoral hypercalcemia |
US5744444A (en) * | 1989-10-27 | 1998-04-28 | Haemopep Pharma Gmbh | HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof |
US5395938A (en) * | 1992-08-21 | 1995-03-07 | Nichols Institute Diagnostics | Biotinylated chemiluminescent labels and their conjugates, assays and assay kits |
US5962637A (en) * | 1994-06-03 | 1999-10-05 | Microbiological Research Authority | Toxin assay |
DE4434551A1 (en) * | 1994-09-28 | 1996-04-04 | Forssmann Wolf Georg Prof Dr D | Peptides from the sequence of hPTH (1-37) |
JP2729159B2 (en) * | 1994-10-31 | 1998-03-18 | 日清製粉株式会社 | Monoclonal antibody of human glicentin, hybridoma producing the antibody, and method for quantifying human glicentin using the same |
GB9507985D0 (en) * | 1995-04-19 | 1995-06-07 | Orion Yhtymae Oy | Antibody to aminoterminal propeptide to type 1 procollagen and assay method using it |
DE19725365B4 (en) * | 1997-06-16 | 2006-05-24 | C. Rob. Hammerstein Gmbh & Co. Kg | Vehicle seat with forwardly displaceable backrest and forwardly displaceable seat support |
US6689566B1 (en) * | 1999-01-14 | 2004-02-10 | Scantibodies Laboratory, Inc. | Methods, kits, and antibodies for detecting parathyroid hormone |
DE19961350A1 (en) | 1999-12-17 | 2001-06-21 | Immundiagnostik Ag | Method for determining parathyroid activity in a human sample |
US6838264B2 (en) * | 2000-12-05 | 2005-01-04 | Immutopics, Inc. | Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
-
2001
- 2001-07-03 US US09/898,398 patent/US20030082179A1/en not_active Abandoned
-
2002
- 2002-07-03 AU AU2002354806A patent/AU2002354806A1/en not_active Abandoned
- 2002-07-03 AT AT02752184T patent/ATE490785T1/en not_active IP Right Cessation
- 2002-07-03 EP EP02752184A patent/EP1455821B1/en not_active Revoked
- 2002-07-03 DE DE60238555T patent/DE60238555D1/en not_active Expired - Lifetime
- 2002-07-03 JP JP2003510000A patent/JP2004536831A/en active Pending
- 2002-07-03 WO PCT/US2002/021356 patent/WO2003003986A2/en active Search and Examination
-
2004
- 2004-08-18 US US10/921,368 patent/US20050003493A1/en not_active Abandoned
-
2005
- 2005-06-06 US US11/146,598 patent/US20060024772A1/en not_active Abandoned
-
2006
- 2006-05-19 US US11/437,428 patent/US20060286107A1/en not_active Abandoned
Non-Patent Citations (7)
Also Published As
Publication number | Publication date |
---|---|
ATE490785T1 (en) | 2010-12-15 |
AU2002354806A1 (en) | 2003-01-21 |
EP1455821A4 (en) | 2006-04-12 |
JP2004536831A (en) | 2004-12-09 |
US20030082179A1 (en) | 2003-05-01 |
US20050003493A1 (en) | 2005-01-06 |
WO2003003986A2 (en) | 2003-01-16 |
US20060286107A1 (en) | 2006-12-21 |
EP1455821B1 (en) | 2010-12-08 |
DE60238555D1 (en) | 2011-01-20 |
US20060024772A1 (en) | 2006-02-02 |
EP1455821A2 (en) | 2004-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003003986A3 (en) | Parathyroid hormone antibodies and related methods | |
WO2002081646A3 (en) | Epitope sequences | |
WO2002079232A3 (en) | Reducing the immunogenicity of fusion proteins | |
EP2287201A3 (en) | RS7 antibodies | |
NZ506086A (en) | Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins, antigens comprising derivatised thiol residues and of compositions for vaccination | |
IL195338A (en) | Antibody comprising an fc variant comprising d or e amino acid substitution at position 239 and pharmaceutical composition and use thereof | |
WO1999003987A3 (en) | Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy | |
JP2002533123A5 (en) | ||
PL392964A1 (en) | Hyperimmune serum reactive antigen, the use of this antigen for the production of a pharmaceutical formulation, fragment of the hiperimmune antigen, antigen auxiliary epitopes, a vaccine containing the hyperimmune serum reactive antigen, formulation containing antibodies, process for the preparation of this formulation, the use of the formulation for the treatment of staphylococcal infections, and screening method | |
WO2001070984A3 (en) | Anti-tissue factor antibodies with enhanced anticoagulant potency | |
WO2005010048A3 (en) | Rg1 antibodies and uses thereof | |
WO2002016401A3 (en) | Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof | |
WO2002074795A3 (en) | Oligomeric complexes of chimeric proteins with enhanced immunogenic potential | |
WO2005058937A3 (en) | A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 | |
WO2005032584A3 (en) | Pertussis antigens and use thereof in vaccination | |
WO2001068708A3 (en) | Human and humanized fap-alpha-specific antibodies | |
WO2001079259A8 (en) | Javelinization of protein antigens to heat shock proteins | |
IS4922A (en) | Polypeptides capable of forming antigen-specific forms of specificity for the resus D antigen, the DNA that represents them, and the method of preparing a saline and its use | |
WO2004035742A3 (en) | Sets of digital antibodies directed against short epitopes, and methods using same | |
WO2002098456A3 (en) | Antigens and vectors for vaccination | |
AU2002217212A1 (en) | Method for preparing a human monoclonal antibody, fragments thereof or antibodies comprising such fragments, resulting antibodies and use thereof | |
WO2001094949A3 (en) | Soluble cd1 compositions and uses thereof | |
WO2003010199A3 (en) | Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques | |
EP1020516A3 (en) | Leptospira vaccine antigens for the prevention of leptospirosis | |
EP1401470A4 (en) | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003510000 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002752184 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWP | Wipo information: published in national office |
Ref document number: 2002752184 Country of ref document: EP |